Tactile Systems Technology (TCMD) - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87357P1003
Tactile Systems Technology, Inc. is a medical technology company that specializes in developing and providing innovative medical devices to treat chronic diseases that often go underserved in the United States.
The company's flagship product, the Flexitouch Plus system, is a pneumatic compression device designed for the treatment of lymphedema in the comfort of one's own home. This device provides a convenient and effective solution for patients dealing with this debilitating condition.
In addition to the Flexitouch Plus system, Tactile Systems Technology also offers the Entre Plus System, a portable pneumatic compression device designed for the at-home treatment of venous disorders, including lymphedema and chronic venous insufficiency, as well as venous leg ulcers. This device provides patients with a convenient and portable solution to manage their condition.
Furthermore, the company has developed Kylee, a mobile application designed to educate patients about lymphedema, track their symptoms and treatment, and share their progress with their doctor. This innovative app empowers patients to take control of their health and stay connected with their healthcare provider.
Tactile Systems Technology also offers the AffloVest, a portable high-frequency chest wall oscillation vest designed to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. This device provides a non-invasive and effective solution for patients dealing with respiratory issues.
Founded in 1995 and headquartered in Minneapolis, Minnesota, Tactile Systems Technology is committed to improving the lives of patients with chronic diseases. With a strong focus on innovation and patient-centric solutions, the company is dedicated to making a positive impact in the healthcare industry.
For more information about Tactile Systems Technology and its innovative products, please visit their website at https://tactilemedical.com.
Drawdown (Underwater) Chart
TCMD Stock Overview
| Market Cap in USD | 342m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 2016-07-28 |
TCMD Stock Ratings
| Growth 5y | -5.01 |
| Fundamental | 52.3 |
| Dividend | - |
| Rel. Performance vs Sector | -5.32 |
| Analysts | 4.67/5 |
| Fair Price Momentum | 12.95 USD |
| Fair Price DCF | 34.93 USD |
TCMD Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
TCMD Growth Ratios
| Growth 12m | -35.93% |
| Growth Correlation 12m | -28% |
| Growth Correlation 3m | -49% |
| CAGR 5y | -22.59% |
| CAGR/Mean DD 5y | -0.42 |
| Sharpe Ratio 12m | -0.79 |
| Alpha vs SP500 12m | -75.28 |
| Beta vs SP500 5y weekly | 1.48 |
| ValueRay RSI | 34.70 |
| Volatility GJR Garch 1y | 49.12% |
| Price / SMA 50 | -8.34% |
| Price / SMA 200 | -6.41% |
| Current Volume | 239.9k |
| Average Volume 20d | 244.4k |
External Links for TCMD Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of May 18, 2024, the stock is trading at USD 13.73 with a total of 239,897 shares traded.
Over the past week, the price has changed by -1.22%, over one month by -3.04%, over three months by -6.41% and over the past year by -33.28%.
According to ValueRays Forecast Model, TCMD Tactile Systems Technology will be worth about 14.5 in May 2025. The stock is currently trading at 13.73. This means that the stock has a potential upside of +5.61%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 20.7 | 50.5 |
| Analysts Target Price | 27.3 | 99.1 |
| ValueRay Target Price | 14.5 | 5.61 |